Related Experiment Video
Updated: May 20, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Radiofrequency radiation and Alzheimer's disease: harmful and therapeutic implications
Hava Bektas1, Suleyman Dasdag2
1Department of Biophysics, Medical School of Van Yuzuncu Yil University, Van, Turkey.
Purpose:
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory loss and cognitive decline. The relationship between AD and radiofrequency (RF) radiation emitted by wireless devices remains under investigation. The aim of this review is to comprehensively explore the effects of RF radiation on AD by evaluating existing literature. This review used Web of Science, Scopus, and PubMed to find relevant studies on AD and RF radiation. This review evaluates a total of 81 studies, including animal models, human studies, and in vitro experiments, with results summarized in tables for clarity.
Conclusion:
Some studies suggest RF aggravates AD by increasing oxidative stress, impairing blood-brain barrier integrity, and promoting amyloid-beta deposition. Conversely, other studies indicate RF may have protective benefits, such as enhancing brain mitochondrial functions and reducing amyloid-beta levels. Understanding the RF-AD relationship, including parameters like frequency and exposure time, is crucial for therapeutic strategies. The studies reviewed highlight RF radiation's dual effects on AD, underscoring the need for a detailed approach. Further studies are required to clarify these effects and inform preventive and therapeutic measures.
More Related Videos
06:22A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid
Published on: September 3, 2021
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...